Sudden death in hypertrophic cardiomyopathy: old risk factors re-assessed in a new model of maximalized follow-up

被引:46
作者
Dimitrow, Pawel Petkow [1 ]
Chojnowska, Lidia [2 ]
Rudzinski, Tomasz [3 ,4 ]
Piotrowski, Walerian [2 ]
Ziolkowska, Lidia [5 ]
Wojtarowicz, Andrzej [6 ]
Wycisk, Anna [7 ]
Dabrowska-Kugacka, Alicja [8 ]
Nowalany-Kozielska, Ewa [9 ]
Sobkowicz, Bozena [10 ]
Wrobel, Wojciech [11 ]
Aleszewicz-Baranowska, Janina [12 ]
Rynkiewicz, Andrzej [13 ]
Loboz-Grudzien, Krystyna [14 ]
Marchel, Michal [15 ]
Wysokinski, Andrzej [16 ]
机构
[1] CMUJ, Dept Cardiol 2, PL-31501 Krakow, Poland
[2] Inst Cardiol, Warsaw, Poland
[3] Univ Med Sci, Dept Cardiol, Lodz, Poland
[4] Univ Med Sci, Chair 2, Lodz, Poland
[5] Childrens Mem Hlth Inst, Dept Pediat Cardiol, Warsaw, Poland
[6] Pomeranian Med Univ, Dept Cardiol, Szczecin, Poland
[7] Univ Silesia, Div Cardiol 3, Katowice, Poland
[8] Med Univ Gdansk, Dept Cardiol & Electrotherapy, Gdansk, Poland
[9] Med Univ Silesia, Dept Cardiol 2, Silesia, Poland
[10] Med Univ, Dept Cardiol 1, Bialystok, Poland
[11] Med Univ Silesia, Dept Cardiol 1, Katowice, Poland
[12] Med Univ Gdansk, Dept Paediat Cardiol & Congenital Heart Dis, Gdansk, Poland
[13] Med Univ Gdansk, Dept Cardiol 1, Gdansk, Poland
[14] Wroclaw Med Univ, Dept Cardiol, Wroclaw, Poland
[15] Med Univ Warsaw, Dept Cardiol 1, Warsaw, Poland
[16] Med Univ, Dept Cardiol, Lublin, Poland
关键词
Hypertrophic cardiomyopathy; Sudden death; Risk factors; LEFT-VENTRICULAR HYPERTROPHY; CARDIAC DEATH; CLINICAL-FEATURES; MUTATIONS; PREVENTION; INFANTS; STRATIFICATION; EPIDEMIOLOGY; PROGNOSIS; CHILDREN;
D O I
10.1093/eurheartj/ehq308
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In hypertrophic cardiomyopathy (HCM), the following five risk factors have a major role in the primary prevention of sudden death (SD): family history of SD (FHSD), syncope, massive wall thickness (MWTh) > 30 mm, non-sustained ventricular tachycardia (nsVT) in Holter monitoring of electrocardiography, and abnormal blood pressure response to exercise (aBPRE). In HCM, as a genetic cardiac disease, the risk for SD may also exist from birth. The aim of the study was to compare the survival curves constructed for each of the five risk factors in a traditional follow-up model (started at the first presentation of a patient at the institution) and in a novel follow-up model (started at the date of birth). In an additional analysis, we compared the survival rate in three subgroups (without FHSD, with one SD, and with two or more SDs in a family). A total of 1306 consecutive HCM patients (705 males, 601 females, mean age of 47 years, and 193 patients were < 18 years) evaluated at 15 referral centres in Poland were enrolled in the study. In a novel method of follow-up, all the five risk factors confirmed its prognostic power (FHSD: P = 0.0007; nsVT: P < 0.0001; aBPRE: P = 0.0081; syncope: P < 0.0001; MWTh P > 0.0001), whereas in a traditional method, only four factors predicted SD (except aBPRE). In a novel model of follow-up, FHSD in a single episode starts to influence the prognosis with a delay to the fifth decade of life (P = 0.0007). Multiple FHSD appears to be a very powerful risk factor (P < 0.0001), predicting frequent SDs in childhood and adolescence. The proposed concept of a lifelong calculated follow-up is a useful strategy in the risk stratification of SD. Multiple FHSD is a very ominous risk factor with strong impact, predicting frequent SD episodes in the early period of life.
引用
收藏
页码:3084 / 3093
页数:10
相关论文
共 37 条
  • [1] Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187
  • [2] Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children - Findings from the Pediatric Cardiomyopathy Registry
    Colan, Steven D.
    Lipshultz, Steven E.
    Lowe, April M.
    Sleeper, Lynn A.
    Messere, Jane
    Cox, Gerald F.
    Lurie, Paul R.
    Orav, E. John
    Towbin, Jeffrey A.
    [J]. CIRCULATION, 2007, 115 (06) : 773 - 781
  • [3] Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene
    Deprez, R. H. Lekanne
    Muurling-Vlietman, J. J.
    Hruda, J.
    Baars, M. J. H.
    Wijnaendts, L. C. D.
    Stolte-Dijkstra, I.
    Alders, M.
    van Hagen, J. M.
    [J]. JOURNAL OF MEDICAL GENETICS, 2006, 43 (10) : 829 - 832
  • [4] Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?
    Ellenbogen, KA
    Levine, JH
    Berger, RD
    Daubert, JP
    Winters, SL
    Greenstein, E
    Shalaby, A
    Schaechter, A
    Subacius, H
    Kadish, A
    [J]. CIRCULATION, 2006, 113 (06) : 776 - 782
  • [5] Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice
    Elliott, P.
    Spirito, P.
    [J]. HEART, 2008, 94 (10) : 1269 - 1275
  • [6] Hypertrophic cardiomyopathy
    Elliott, P
    McKenna, WJ
    [J]. LANCET, 2004, 363 (9424) : 1881 - 1891
  • [7] Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy
    Elliott, P. M.
    Gimeno, J. R.
    Thaman, R.
    Shah, J.
    Ward, D.
    Dickie, S.
    Esteban, M. T. Tome
    McKenna, W. J.
    [J]. HEART, 2006, 92 (06) : 785 - 791
  • [8] The Science of Uncertainty and the Art of Probability Syncope and Its Consequences in Hypertrophic Cardiomyopathy
    Elliott, Perry
    McKenna, William
    [J]. CIRCULATION, 2009, 119 (13) : 1697 - 1699
  • [9] Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy
    Elliott, Perry M.
    Gimeno, Juan R.
    Tome, Maria T.
    Shah, Jaymin
    Ward, Deirdre
    Thaman, Rajesh
    Mogensen, Jens
    McKenna, William J.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 (16) : 1933 - 1941
  • [10] Sudden death in hypertrophic cardiomyopathy: Identification of high risk patients
    Elliott, PM
    Poloniecki, J
    Dickie, S
    Sharma, S
    Monserrat, L
    Varnava, A
    Mahon, NG
    McKenna, WJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (07) : 2212 - 2218